Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$446.73 - $548.2 $610,679 - $749,389
-1,367 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$478.3 - $607.98 $18,175 - $23,103
38 Added 2.86%
1,367 $660,000
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $71,362 - $86,225
131 Added 10.93%
1,329 $744,000
Q2 2020

Aug 11, 2020

SELL
$493.32 - $643.92 $1,973 - $2,575
-4 Reduced 0.33%
1,198 $747,000
Q1 2020

May 08, 2020

BUY
$336.18 - $494.43 $53,788 - $79,108
160 Added 15.36%
1,202 $587,000
Q4 2019

Feb 11, 2020

SELL
$274.13 - $376.51 $43,586 - $59,865
-159 Reduced 13.24%
1,042 $391,000
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $7,656 - $8,914
-28 Reduced 2.28%
1,201 $333,000
Q2 2019

Jul 31, 2019

SELL
$299.6 - $414.82 $34,753 - $48,119
-116 Reduced 8.62%
1,229 $385,000
Q1 2019

May 06, 2019

SELL
$372.08 - $439.57 $42,045 - $49,671
-113 Reduced 7.75%
1,345 $552,000
Q4 2018

Feb 13, 2019

SELL
$335.82 - $403.04 $32,574 - $39,094
-97 Reduced 6.24%
1,458 $545,000
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $40,381 - $46,978
115 Added 7.99%
1,555 $628,000
Q2 2018

Aug 03, 2018

BUY
$284.6 - $344.99 $36,998 - $44,848
130 Added 9.92%
1,440 $497,000
Q1 2018

May 03, 2018

BUY
$315.82 - $393.78 $25,897 - $32,289
82 Added 6.68%
1,310 $451,000
Q4 2017

Feb 02, 2018

SELL
$358.63 - $469.95 $20,083 - $26,317
-56 Reduced 4.36%
1,228 $462,000
Q3 2017

Nov 03, 2017

BUY
$431.38 - $504.0 $553,891 - $647,136
1,284
1,284 $574,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $111B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.